Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The function and dysfunction of memory CD8+ T cells in tumor immunity
James L. Reading, Felipe Gálvez‐Cancino, Charles Swanton, et al.
Immunological Reviews (2018) Vol. 283, Iss. 1, pp. 194-212
Open Access | Times Cited: 142

Showing 26-50 of 142 citing articles:

Glycolysis inhibition induces anti-tumor central memory CD8+T cell differentiation upon combination with microwave ablation therapy
Xinyu Tang, Xinrui Mao, Peiwen Ling, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
ECSIT facilitates memory CD8+ T cell development by mediating fumarate synthesis during viral infection and tumorigenesis
Yongbing Yang, Yanan Wang, Zhongcheng Wang, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 3, pp. 450-463
Closed Access | Times Cited: 9
A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer
Lijuan Chen, Pengju Wang, Carmela Di Gioia, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Immune Modulating Antibody–Drug Conjugate (IM-ADC) for Cancer Immunotherapy
Lei He, Liangliang Wang, Zhisong Wang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 21, pp. 15716-15726
Closed Access | Times Cited: 49
The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor
Xinru Chen, Xiangchan Hong, Gang Chen, et al.
Translational Oncology (2022) Vol. 17, pp. 101338-101338
Open Access | Times Cited: 33
Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer
Yuru Chen, Jiazheng Sun, Yachan Luo, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Neoantigens in precision cancer immunotherapy: from identification to clinical applications
Qiao Zhang, Qingzhu Jia, Jing Zhang, et al.
Chinese Medical Journal (2022) Vol. 135, Iss. 11, pp. 1285-1298
Open Access | Times Cited: 29
Spatial features of specific CD103+CD8+ tissue-resident memory T cell subsets define the prognosis in patients with non-small cell lung cancer
Guanqun Yang, Siqi Cai, Mengyu Hu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment
Yien Ning Sophia Wong, Kroopa Joshi, Pramit Khetrapal, et al.
The Journal of Experimental Medicine (2018) Vol. 215, Iss. 11, pp. 2748-2759
Open Access | Times Cited: 49
The Janus Face of Tumor Microenvironment Targeted by Immunotherapy
Maria Buoncervello, Lucia Gabriele, Elena Toschi
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4320-4320
Open Access | Times Cited: 47
TGF-β1 Induces Immune Escape by Enhancing PD-1 and CTLA-4 Expression on T Lymphocytes in Hepatocellular Carcinoma
Shixiang Bao, Xiaopei Jiang, Shuai Jin, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 40
Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma
Julia Peña‐Asensio, Henar Calvo Sánchez, Miguel Torralba, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1922-1922
Open Access | Times Cited: 39
Iron oxide nanoparticles for immune cell labeling and cancer immunotherapy
Seokhwan Chung, Richard A. Revia, Miqin Zhang
Nanoscale Horizons (2021) Vol. 6, Iss. 9, pp. 696-717
Open Access | Times Cited: 39
Dietary supplementation with astaxanthin enhances anti-tumor immune response and aids the enhancement of molecularly targeted therapy for hepatocellular carcinoma
Pengfei Ren, Xinyue Yu, Xiangan Han, et al.
Food & Function (2023) Vol. 14, Iss. 18, pp. 8309-8320
Closed Access | Times Cited: 13
Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2−) Breast Cancer
Yuanping Hu, Shouman Wang, Nianhua Ding, et al.
Clinical Breast Cancer (2020) Vol. 20, Iss. 4, pp. e403-e409
Closed Access | Times Cited: 35
ABC Transporters in T Cell-Mediated Physiological and Pathological Immune Responses
Christoph Thurm, Burkhart Schraven, Sascha Kahlfuß
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9186-9186
Open Access | Times Cited: 32
Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal
Sho Isoyama, Shigeyuki Mori, Daisuke Sugiyama, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002279-e002279
Open Access | Times Cited: 30
Bystander CD4+ T cells infiltrate human tumors and are phenotypically distinct
Shamin Li, Summer Zhuang, Antja Heit, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 20
Tertiary lymphoid structures: Associated multiple immune cells and analysis their formation in hepatocellular carcinoma
Ye Nie, Hanlu Fan, Jianhui Li, et al.
The FASEB Journal (2022) Vol. 36, Iss. 11
Open Access | Times Cited: 20
Activated Natural Killer Cells‐Dependent Dendritic Cells Recruitment and Maturation by Responsive Nanogels for Targeting Pancreatic Cancer Immunotherapy
Junjie Deng, Weide Xu, Siyun Lei, et al.
Small (2022) Vol. 18, Iss. 44
Closed Access | Times Cited: 19
Tissue-resident memory T cells in urinary tract diseases
Guofeng Xu, Yuying Li, Guanting Lu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
A comprehensive review on targeting diverse immune cells for anticancer therapy: beyond immune checkpoint inhibitors
Dequan Liu, Lei Liu, Xinming Zhao, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 210, pp. 104702-104702
Open Access
New insights into T cell metabolism in liver cancer: from mechanism to therapy
Jie Xiao, Ting Liu, Fanxin Zeng, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannoma
Adam P. Jones, Michael Haley, Miriam Hernandez-Meadows, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Association between MRI-measured bone marrow cellularity and clinical outcomes among cervical cancer patients treated with PD-1 inhibitors
Jie Lou, Yi Li, Ruijie Li, et al.
International Journal of Gynecological Cancer (2025), pp. 101808-101808
Closed Access

Scroll to top